Genzyme's MS drug rejected by FDA

Genzyme's MS drug rejected by FDA

The decision Monday essentially codifies weeks of unfavorable reviews from the US regulator, including an alarming report in November from an FDA panel of medical advisers that warned of rashes, bleeding, and even thyroid cancer as possible side effects.

8
Like
Save

Comments

Write a comment

*